AstraZeneca PLC (AZN) vs BlackRock, Inc. (BLK)
AZN leads on 9 of 14 compared metrics, though BLK is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and BlackRock, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs BLK
growth of $100 · last 27yAZN +323.1%BLK +7203.6%BLK compounded faster
Log scale — wide-divergence pair
AZN BLK
AZN vs BLK: by the numbers
- •AZN is the larger company ($277.22B vs $160.20B market cap).
- •BLK trades at the lower earnings multiple (25.90 vs 26.92 P/E).
- •BLK converts more revenue to profit (24.33% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 8.76% CAGR).
- •BLK pays the higher dividend yield (2.12% vs 1.79%).
Which is better, AZN or BLK?
Metric tally: AZN 9 · BLK 5It depends on what you're optimizing for:
ValueBLK(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeBLK(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | BLK |
|---|---|---|
| P/E ratio | 26.92 | 25.90● |
| Forward P/E | 15.33● | 19.40 |
| P/S ratio | 4.62● | 6.62 |
| P/B ratio | 5.90 | 3.00● |
| PEG ratio | 0.14● | 11.72 |
| EV / EBITDA | 14.92 | — |
| FCF yield | 2.89% | — |
Profitability
| Metric | AZN | BLK |
|---|---|---|
| Gross margin | 81.68%● | 59.14% |
| Operating margin | 23.69% | 29.87%● |
| Net margin | 17.19% | 24.33%● |
| ROE | 21.95%● | 11.03% |
| ROIC | 13.03%● | 3.27% |
Dividends
| Metric | AZN | BLK |
|---|---|---|
| Dividend yield | 1.79% | 2.12%● |
| Payout ratio | 48.48% | 61.05% |
Growth (annualized)
| Metric | AZN | BLK |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 8.76% |
| EPS CAGR (5Y) | 22.02%● | 2.21% |
| FCF CAGR (5Y) | 15.68% | — |
| Total return CAGR (5Y) | 11.03%● | 5.76% |
Frequently asked
- Which is better, AZN or BLK?
- It depends on your goal. value: BLK (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: BLK (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 9 to 5.
- Is AZN or BLK cheaper?
- On trailing earnings, BLK is cheaper: AZN trades at a 26.92 P/E and BLK at 25.90.
- Which has grown faster, AZN or BLK?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus BLK at 8.76%.
- Does AZN or BLK pay a bigger dividend?
- AZN yields 1.79% and BLK yields 2.12% based on trailing dividends and the latest price.
- Is AZN or BLK more profitable?
- BLK runs the higher net margin — AZN at 17.19% versus BLK at 24.33%.
- Which has been the better investment, AZN or BLK?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus BLK at 14.30%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioBlackRock P/E ratioAstraZeneca dividend yieldBlackRock dividend yieldAstraZeneca ROEBlackRock ROEAstraZeneca operating marginBlackRock operating marginAstraZeneca revenue growthBlackRock revenue growthAstraZeneca free cash flowBlackRock free cash flow
AstraZeneca & BlackRock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.